Eren, F. Et Al. 2013. PRELIMINARY EVIDENCE OF A REDUCED SERUM LEVEL OF FIBROBLAST GROWTH FACTOR 19 IN PATIENTS WITH BIOPSY-PROVEN NONALCOHOLIC FATTY LIVER DISEASE. International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL) , (Amsterdam, Netherlands).

Eren, F., Kurt, R., Ermis, F., Atug, O., Imeryuz, N., & Yilmaz, Y., (2013). PRELIMINARY EVIDENCE OF A REDUCED SERUM LEVEL OF FIBROBLAST GROWTH FACTOR 19 IN PATIENTS WITH BIOPSY-PROVEN NONALCOHOLIC FATTY LIVER DISEASE . International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Amsterdam, Netherlands

Eren, F. Et Al. "PRELIMINARY EVIDENCE OF A REDUCED SERUM LEVEL OF FIBROBLAST GROWTH FACTOR 19 IN PATIENTS WITH BIOPSY-PROVEN NONALCOHOLIC FATTY LIVER DISEASE," International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Amsterdam, Netherlands, 2013

Eren, F. Et Al. "PRELIMINARY EVIDENCE OF A REDUCED SERUM LEVEL OF FIBROBLAST GROWTH FACTOR 19 IN PATIENTS WITH BIOPSY-PROVEN NONALCOHOLIC FATTY LIVER DISEASE." International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL) , Amsterdam, Netherlands, 2013

Eren, F. Et Al. (2013) . "PRELIMINARY EVIDENCE OF A REDUCED SERUM LEVEL OF FIBROBLAST GROWTH FACTOR 19 IN PATIENTS WITH BIOPSY-PROVEN NONALCOHOLIC FATTY LIVER DISEASE." International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL) , Amsterdam, Netherlands.

@conferencepaper{conferencepaper, author={F. Eren Et Al. }, title={PRELIMINARY EVIDENCE OF A REDUCED SERUM LEVEL OF FIBROBLAST GROWTH FACTOR 19 IN PATIENTS WITH BIOPSY-PROVEN NONALCOHOLIC FATTY LIVER DISEASE}, congress name={International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL)}, city={Amsterdam}, country={Netherlands}, year={2013}}